![[H-3] GSK1059865](https://strapi.rctritec.com/uploads/image_2_db1d865e79.png)
[H-3] GSK1059865
En stock et expédié sous 1 à 2 semainesQuantité
Key Facts
- Numéro de catalogue
- RCTT0402
- CAS
- 1191044-58-2
- Formule moléculaire
- C20H23BrFN3O2
- Poids moléculaire
- 436.32 g/mol
- Specific Activity Range
- 38-60 Ci/mmol (1406-2220 GBq/mmol)
- Concentration
- 1 mCi/ml (37 MBq/ml) in ethanol.
Description
Selective orexin/hypocretin receptor type 1 antagonist.
Caractéristiques techniques
- Nom du produit
- [H-3] GSK1059865
- Numéro de catalogue
- RCTT0402
- Numéro CAS
- 1191044-58-2
- Formule moléculaire
- C20H23BrFN3O2
- Poids moléculaire
- 436.32 g/mol
- Concentration
- 1 mCi/ml (37 MBq/ml) in ethanol.
- Pureté radiochimique
- The radiochemical purity after purification was determined to be >97%.
- Activité spécifique
- 38-60 Ci/mmol (1406-2220 GBq/mmol)
- Expédition
- Shipped at ambient temperature.
Stockage et stabilité
The initial rate of degradation of this compound, stored as received, at temperatures below -60 °C in the dark, is initially 3% for 12 months starting from the date of purification. The decomposition of the compound is not linear or related to isotope half-life. Deviations of different lots may occur.
Sécurité et conformité
The mass spectrum is consistent with the proposed structure and a non-labeled reference; the HPLC retention time is consistent with a non-labeled reference. For research and development use only, not for use in humans. This compound could induce cancer.